Literature DB >> 4650967

Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment.

J C Ruckdeschel, S D Codish, A Stranahan, M F McKneally.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4650967     DOI: 10.1056/NEJM197211162872004

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  34 in total

1.  Common infections in the history of cancer patients and controls.

Authors:  U Abel; N Becker; R Angerer; R Frentzel-Beyme; M Kaufmann; P Schlag; S Wysocki; J Wahrendorf; G Schulz
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Tunneled pleural catheter use for pleural palliation does not increase infection rate in patients with treatment-related immunosuppression.

Authors:  Candice L Wilshire; Christopher R Gilbert; Brian E Louie; Ralph W Aye; Alexander S Farivar; Eric Vallières; Jed A Gorden
Journal:  Support Care Cancer       Date:  2017-11-29       Impact factor: 3.603

3.  Postpancreatectomy hemorrhage (PPH): predictors and management from a prospective database.

Authors:  B Darnis; R Lebeau; X Chopin-Laly; M Adham
Journal:  Langenbecks Arch Surg       Date:  2013-02-26       Impact factor: 3.445

4.  Current status of immunotherapy for the treatment of lung cancer.

Authors:  Sanjay Murala; Vamsi Alli; Daniel Kreisel; Andrew E Gelman; Alexander S Krupnick
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

5.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

6.  Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.

Authors:  W Bakker; J M Nijhuis-Heddes; E A van der Velde
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Postoperative empyema and survival in lung cancer.

Authors: 
Journal:  Br Med J       Date:  1973-03-03

8.  Quality of survival in patients with surgically treated bronchial carcinoma.

Authors:  E Nõu; T Aberg
Journal:  Thorax       Date:  1980-04       Impact factor: 9.139

9.  Intrapleural and intravenous Corynebacterium parvum in patients with resected stage I and II non-small cell carcinoma of the lung. The Ludwig Lung Cancer Study Group.

Authors: 
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  A case of spontaneous regression of advanced gastric cancer.

Authors:  Ho Sang Lee; Dae Young Cheung; Jin Il Kim; Se Hyun Cho; Soo-Heon Park; Joon-Yeol Han; Jae Kwang Kim
Journal:  J Korean Med Sci       Date:  2010-09-20       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.